| BCBS Highmark Penn Medicare Advantage | Wound Care | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Removal of Benign Skin Lesions | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Linvoseltamab-gcpt (Lynozyfic) | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Nipocalimab-aahu (Imaavy) | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Gemcitabine | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Intravesical Mitomycin (Zusduri) | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Rozanolixizumab-noli (Rystiggo) | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Telisotuzumab vedotin-tllv (Emrelis) | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Carboplatin (Paraplatin) | 2026-01-01 |
| BCBS Highmark Penn Medicare Advantage | Ustekinumab (Stelara) and Ustekinumab Biosimilars | 2026-01-01 |